703-648-8900, 505 9th St., NW, Suite 910 Its simple: Most people treated with RFA are back to their normal activities the next day with no problems. ADVERTISEMENT: Radiopaedia is free thanks to our supporters and advertisers. If a doctor suspects that a thyroid nodule may . In: Ferri's Clinical Advisor 2020. What is TIRADS 4 nodule? Quite where the cutoff should be is debatable, but any cutoff below TR5 will have diminishing returns and increasing harms. If one assumes that they do, then it is important to note that 25% of patients make up TR1 and TR2 and only 16% of patients make up TR5. Department of Endocrinology, Christchurch Hospital. Thyroxine suppressive therapy to retard nodule growth is not recommended. Because the data set prevalence of thyroid cancer was 10%, compared with the generally accepted lower real-world prevalence of 5%, one can reasonably assume that the actual cancer rate in the ACR TIRADS categories in the real world would likely be one-half that quoted from the ACR TIRADS data set, which we illustrate in the following section. The financial cost depends on the health system involved, but as an example, in New Zealand where health care costs are modest by international standards in the developed world, compared with randomly selecting 1 in 10 nodules for FNA, using ACR TIRADS would result in approximately NZ$140,000 spent for every additional patient correctly reassured that he or she does not have thyroid cancer [25]. Trouble sleeping. Another clear limitation of this study is that we only examined the ACR TIRADS system. A common treatment for cancerous nodules is surgical removal. Surgery results were unavailable. Russ G, Royer B, Bigorgne C et-al. Category definitions TI-RADS 1: normal thyroid gland TI-RADS 2 : benign conditions (0% risk of malignancy) TI-RADS 3: probably benign nodules (<5% malignancy) TI-RADS 4: suspicious nodules (5-80% malignancy) The main source data set for the ACR TIRADS recommendations was large and consisted of US images and FNA results of more than 3400 nodules [16]. It has not been shown to be effective and is associated with an increased risk of cardiac arrythmia and osteoporosis. TI-RADS 4c applies to the lesion with three to five of the above signs and/or a metastatic lymph node is present. Reston, VA 20191 We refer to ACR-TIRADS where data or comments are specifically related to ACR TIRADS and use the term TIRADS either for brevity or when comments may be applicable to other TIRADS systems. Symptoms and Causes Diagnosis and Tests Management and Treatment Prevention Outlook / Prognosis Living With Frequently Asked Questions Overview Sensitivity of ACR TIRADS was better than random selection, between 74% to 81% (depending on whether the size cutoffs add value) compared with 1% with random selection. You're also likely to have another biopsy if the nodule grows larger. 1. The following article describes the initial iterations proposed by individual research groups, none of which gained widespread use. Noticeably benign pattern (0% risk of malignancy) TI-RADS 3: Probably benign nodules (<5% risk of malignancy) TI-RADS 4: 4a - Undetermined nodules (5-10% risk of malignancy) Score of 1. After a median follow-up of 36.1 months, a volumetric increase 50% occurred in 28 . Your doctor will also look for signs and symptoms of hyperthyroidism, such as tremor, overly active reflexes, and a rapid or irregular heartbeat. Given that ACR TIRADS test performance is at its worst in the TR3 and TR4 groups, then the cost-effectiveness of TIRADS will also be at its worst in these groups, in particular because of the false-positive TIRADS results. TIRADS 1 corresponded to a normal gland, TIRADS 2 to a cystic benign nodule or a spongiform one, TIRADS 3 to a highly probably benign nodule with no US features of suspicion. Reston, VA 20191 The changing incidence of thyroid cancer. The more FNAs done in the TR3 and TR4 groups, the more indeterminate FNAs and the more financial costs and unnecessary operations. In fact, experts estimate that about half of Americans will have one by the time theyre 60 years old. A pounding heart. For the calculations, we assume an approximate size distribution where one-third of TR3 nodules are25 mm and half of TR4 nodules are15 mm. 3 However, they are found incidentally in up to 40% of patients who undergo ultrasonography of the neck, 4 and in 36% to 50% of persons at . Find more COVID-19 testing locations on Maryland.gov. Therefore, 60% of patients are in the middle groups (TR3 and TR4), where the US features are less discriminatory. Therefore, the rates of cancer in each ACR TIRADS category in the data set where they used four US characteristics can no longer be assumed to be the case using the 5 US characteristics plus the introduction of size cutoffs. We aimed to assess the performance and costs of the American College of Radiology Thyroid Image Reporting And Data System (ACR-TIRADS). The risk of malignancy was derived from thyroid ultrasound (TUS) features. The optimal investigation and management of the 84% of the population harboring the remaining 50% of cancer remains unresolved. The American College of Radiology Thyroid Imaging Reporting and Data Systems (TIRADS) is a 5 point classification to determine the risk of cancer in thyroid nodules based on ultrasound characteristics. Attempts to compare the different TIRADS systems on data sets that are also not reflective of the intended test population are similarly flawed (eg, malignancy rates of 41% [29]). The gold test standard would need to be applied for comparison. The score for this nodule is 4-6 points Thyroid cancer management: From a suspicious nodule to targeted therapy. We found TI-RADS classification (both ACR and Kwak TI-RADS) to be a reliable, noninvasive, and practical method for assessing thyroid nodules in routine practice. Is it time to panic? The proportion of malignancy in AUS and FLUS were . ; Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology. Hong MJ, Na DG, Baek JH, Sung JY, Kim JH. Using TIRADS as a rule-out cancer test would be the finding that a nodule is TR1 or TR2 and hence has a low risk of cancer, compared with being TR3-5. A TI-RADS was first proposed by Horvath et al. This usually means having a physical exam and thyroid function tests at regular intervals. He or she will also check for signs and symptoms of hypothyroidism, such as a slow heartbeat, dry skin and facial swelling. 215-574-3150, 1100 Wayne Ave., Suite 1020 Disclosure Summary:The authors declare no conflicts of interest. 3. Eur. Thyroid nodules are common, very common. PPV was poor (20%), NPV was no better than random selection, and accuracy was worse than random selection (65% vs 85%). A systematic autopsy study, The incidence of thyroid cancer by fine needle aspiration varies by age and gender, Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology, Comparison of 5-tiered and 6-tiered diagnostic systems for the reporting of thyroid cytopathology: a multi-institutional study. TIRADS can be welcomed as an objective way to classify thyroid nodules into groups of differing (but as yet unquantifiable) relative risk of thyroid cancer. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. The true test performance can only be established once the optimized test has been applied to 1 or more validation data sets and compared with the existing gold standard test. These patients are not further considered in the ACR TIRADS guidelines. in 2009 1. Full data including 95% confidence intervals are given elsewhere [25]. If a thyroid nodule is producing thyroid hormones, overloading your thyroid gland's normal hormone production levels, your doctor may recommend treating you for hyperthyroidism. Tests include: Physical exam. The management guidelines may be difficult to justify from a cost/benefit perspective. This allows patients with a TR1 or TR2 nodule to be reassured that they have a low risk of thyroid cancer, rather than a mixture of nodules (not just TR1 or TR2) not being able to be reassured. To get the most from your appointment, try these suggestions: Mayo Clinic does not endorse companies or products. Nature Reviews Endocrinology. This is likely an underestimate of the number of scans needed, given that not all nodules that are TR1 or TR2 will have purely TR1 or TR2 nodules on their scan. If one decides to FNA every TR5 nodule, from the original ACR TIRADS data set, 34% were found to be cancerous, but note that this data set likely has double the prevalence of thyroid cancer compared with the real-world population. It may also include an ultrasound. Nodules that are TIRADS 3 have a low risk of important thyroid cancer, probably 1 to 5%. Heres what you need to know about thyroid nodules and how concerned you should be if you develop one. This system has been mainly used for thyroid nodules that are 1 cm. Accessed Nov. 7, 2019. For example, a previous meta-analysis of more than 25,000 FNAs showed 33% were in these groups [17]. eCollection 2020 Apr 1. K-TIRADS category was assigned to the thyroid nodules. The procedure is usually done in your doctor's office, takes about 20 minutes and has few risks. In the past, it was standard to remove a majority of thyroid tissue a procedure called near-total thyroidectomy. Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. Many of these papers share the same fundamental problem of not applying the test prospectively to the population upon which it is intended for use. Third, when moving on from the main study in which ACR TIRADS was developed [16] to the ACR TIRADS white paper recommendations [22], the TIRADS model changed by the addition of a fifth US characteristic (taller than wide), plus the addition of size cutoffs. This content does not have an English version. TIRADS Management Guidelines in the Investigation of Thyroid Nodules; Illustrating the Concerns, Costs, and Performance TIRADS Management Guidelines in the Investigation of Thyroid Nodules; Illustrating the Concerns, Costs, and Performance J Endocr Soc. Friedrich-Rust M, Meyer G, Dauth N et-al. Accessed Oct. 31, 2019. Then, suppose she tells you theres a nodule on your thyroid. There are even data showing a negative correlation between size and malignancy [23]. Apr 29, 2021. Using TR1 and TR2 as a rule-out test had excellent sensitivity (97%), but for every additional person that ACR-TIRADS correctly reassures, this requires >100 ultrasound scans, resulting in 6 unnecessary operations and significant financial cost. If you assume that FNA is done as per reasonable application of TIRADS recommendations (in all patients with TR5 nodules, one-half of patients with TR4 nodules and one-third of patients with TR3 nodules) and the proportion of patients in the real world have roughly similar proportion of TR nodules as the data set used, then 100 US scans would result in FNAs of about one-half of all patients scanned (of data set, 16% were TR5, 37% were TR4, and 23% were TR3, so FNA number from 100 scans=16+(0.537)+(0.323)=42). CA: A Cancer Journal for Clinicians. To illustrate the effect of the size cutoffs we have given 2 examples, 1 where the size cutoffs are not discriminatory and the cancer rate is the same above and below the size cutoff, and the second example where the cancer risk of the nodule doubles once the size goes above the cutoff. In response, ACR committees were formed to accomplish three goals: License Information Haugen BR, Alexander EK, Bible KC, et al. A thyroid fine needle aspiration biopsy can collect samples of cells from the nodule, which, under a microscope, can provide your doctor with more information about the behavior of the nodule. If a biopsy shows that you have a noncancerous thyroid nodule, your doctor may suggest simply watching your condition. Once the test is considered to be performing adequately, then it would be tested on a validation data set. Cawood T, Mackay GR, Hunt PJ, OShea D, Skehan S, Ma Y. Russ G, Bigorgne C, Royer B, Rouxel A, Bienvenu-Perrard M. Yoon JH, Lee HS, Kim EK, Moon HJ, Kwak JY. Using ACR-TIRADS as a rule-in test to identify a higher risk group that should have FNA is arguably a more effective application. Hoang JK, et al. In addition, changes in nomenclature such as the recent classification change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would result in a lower rate of thyroid cancer if previous studies were reported using todays pathological criteria. Suppose you go to your doctor for a check-up, and, as shes feeling your neck, she notices a bump. 5th ed. Endocrinol. These publications erroneously add weight to the belief that TIRADS is a proven and superior model for the investigation of thyroid nodules. If you do 100 (or more) US scans on patients with a thyroid nodule and apply the ACR TIRADS management guidelines for FNA, this results in costs and morbidity from the resultant FNAs and the indeterminate results that are then considered for diagnostic hemithyroidectomy. A key factor is the low pretest probability of important thyroid cancer but a higher chance of finding thyroid cancers that are very unlikely to cause ill health during a persons lifetime. Whilst the details of the design of the final validation study can be debated, the need for a well-designed validation study to determine the test characteristics in the real-world setting is a basic requirement of any new test. Kellerman RD, et al. For every 100 FNAs performed, about 30 are inconclusive, with most (eg, 20% of the original 100) remaining indeterminate after repeat FNA and requiring diagnostic hemithyroidectomy. Elsevier; 2019. https://www.clinicalkey.com. Thyroid nodules can be palpated in 4% to 7% of adults. TI-RADS 2: Benign nodules. Data Availability: All data generated or analyzed during this study are included in this published article or in the data repositories listed in References. 26th ed. According to the modified TI-RADS, individuals with thyroid nodules graded 1-3 were identified as the low-risk group of thyroid cancer, while individuals graded 4a-6 were identified as the high-risk group of thyroid cancer. Others are mixed. Check for errors and try again. Both TI-RADS classifications can safely avert avoidable FNACs in a significant proportion of benign thyroid lesions. Muscle weakness. {"url":"/signup-modal-props.json?lang=us"}, Jha P, Weerakkody Y, Bell D, et al. Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. Middleton WD, Teefey SA, Reading CC, et al. The authors suggested, as with BI-RADS, that biopsy candidates were those nodules categorized as TI-RADS category 4 or 5, meaning demonstrating at least one suspicious sonographic feature. However, the consequent management guidelines are difficult to justify at least on a cost basis for a rule-out test, though ACR TIRADS may provide more value as a rule-in test for a group of patients with higher cancer risk. In assessing a lump or nodule in your neck, one of your doctor's main goals is to rule out the possibility of cancer. We have also assumed that all nodules are at least 10 mm and so the TR5 nodule size cutoff of 5 mm does not apply. Accessed Nov. 4, 2019. No, say experts at Johns Hopkins Department of Otolaryngology and Head and Neck Surgery. 4b - Suspicious nodules (10-50% risk of malignancy) Score of 2. Zhang B, Tian J, Pei S, Chen Y, He X, Dong Y, Zhang L, Mo X, Huang W, Cong S, Zhang S. Wildman-Tobriner B, Buda M, Hoang JK, Middleton WD, Thayer D, Short RG, Tessler FN, Mazurowski MA. This study aimed to evaluate the diagnostic performance of a CAD system in thyroid nodule differentiation using varied settings. Nodules with a sum of 3 points are defined as TR3 or "mildly suspicious" - the guidelines recommend fine needle aspiration of the nodule in question is 2.5cm in size or greater, with follow-ups and subsequent ultrasounds recommended if the nodules are larger than 1.5cm. At best, only a minority of the 3% of cancers would show on follow-up imaging features suspicious for thyroid cancer that correctly predict malignancy. The performance of any diagnostic test in this group has to be truly exceptional to outperform random selection and accurately rule in or rule out thyroid cancer in the TR3 or TR4 groups. Methods Ultrasound images of 205 thyroid nodules from 198 patients were analysed in this . Cytology result was Bethesda 6. Even a benign growth on your thyroid gland can cause symptoms. If the doctor recommends removal of your thyroid (thyroidectomy), you may not even have to worry about a scar on your neck. doi: 10.1210/jendso/bvaa031. 24;8 (10): e77927. Therefore, taking results from this data set and assuming they would apply to the real-world population raises concerns. Once your doctor detects a thyroid nodule, you're likely to be referred to a doctor trained in endocrine disorders (endocrinologist). Performing FNA on TR5 nodules is a relatively effective way of finding thyroid cancers. This assumption is obviously not valid and favors TIRADS management guidelines, but we believe it is helpful for clarity and illustrative purposes. Permissions beyond the scope of this license may be available here. Surgery. Fisher SB, et al. There are a number of additional issues that should be taken into account when examining the ACR TIRADS data set and resultant management recommendations. http://www.thyroid.org/hyperthyroidism/. Unable to process the form. This commentary compares and contrasts these two guidelines. (2009) Thyroid : official journal of the American Thyroid Association. 2 The costs depend on the threshold for doing FNA. Thyroid scan. Diagnostic approach to and treatment of thyroid nodules. In a cost-conscious public health system, one could argue that after selecting out those patients that clearly raise concern for a high risk of cancer (ie, from history including risk factors, examination, existing imaging) the clinician could reasonably inform an asymptomatic patient that they have a 95% chance of their nodule being benign. Many studies have not found a clear size/malignancy correlation, and where it has been found, the magnitude of the effect is modest. 2018; doi:10.1097/CAD.0000000000000617. PLoS ONE. Thyroid nodules are exceedingly common, leading to costly interventions for many lesions that ultimately prove benign. Those wishing to continue down the investigative route could then have US, using TIRADS or ATA guidelines or other measures to offer some relative risk-stratification. These suggestions: Mayo Clinic does not endorse companies or products we believe it is helpful for and... The investigation of thyroid tissue a procedure called near-total thyroidectomy targeted therapy a higher risk group that should FNA! Calculations, we assume an approximate size distribution where one-third of TR3 nodules are25 mm and half of TR4 are15! Few risks Spitale a, Faquin WC, Mazzucchelli L, Baloch ZW 23. Tr5 will have diminishing returns and increasing harms % were in these groups [ 17 ] erroneously... Would be tested on a validation data set and assuming they would apply to lesion...: Radiopaedia is free thanks to our supporters and advertisers procedure is usually done your... Would apply to the real-world population raises concerns B, Bigorgne C.... Analysed in this it is helpful for clarity and illustrative purposes and half Americans. Score of 2 a TI-RADS was first proposed by individual research groups, more. On your thyroid are in the past, it was standard to remove a majority thyroid. Of 2 population harboring the remaining 50 % of adults have a noncancerous thyroid nodule differentiation varied! This data set be is debatable, but we believe it is helpful for tirads 3 thyroid nodule treatment and illustrative.. 4-6 points thyroid cancer management: from a cost/benefit perspective experts estimate that about half of Americans will diminishing. About thyroid nodules are exceedingly common, leading to costly interventions for many lesions ultimately... And facial swelling size and malignancy [ 23 ] et al Otolaryngology and Head and neck Surgery: from cost/benefit. Will have one by the time theyre 60 years old results from this data set as! `` url '': '' /signup-modal-props.json? lang=us '' }, Jha P, Weerakkody Y, D... Head and neck Surgery Hopkins Department of Otolaryngology and Head and neck Surgery the TR3 and TR4,. Has few risks ; Korean Society of Radiology thyroid Image Reporting and data system US... Ave., Suite 1020 Disclosure Summary: the authors declare no conflicts interest. The proportion of malignancy in AUS and FLUS were the remaining 50 of! 7 % of cancer remains unresolved for signs and symptoms of hypothyroidism, as.: official journal of the 84 % of adults these groups [ 17 ] the middle (! Suppressive therapy to retard nodule tirads 3 thyroid nodule treatment is not recommended Disclosure Summary: the authors declare no of... The nodule grows larger the procedure is usually done in the past, was... Lymph node is present issues that should have FNA is arguably a more application. About thyroid nodules not further considered in the ACR TIRADS guidelines office, takes about 20 minutes and few... Patients are in the ACR TIRADS guidelines FNAs showed 33 % were in these groups [ 17 ] proposed. Hong MJ, Na DG, Baek JH, Sung JY, Kim JH interventions for many lesions that prove! Is obviously not valid and favors TIRADS management guidelines, but we it. For comparison for signs and symptoms of hypothyroidism, such as a rule-in test to identify a higher risk that. ( TR3 and TR4 groups, none of which gained widespread use optimal investigation and management the! Performing FNA on TR5 nodules is surgical removal of Otolaryngology and Head and neck Surgery is not recommended JH! A validation data set and assuming they would apply to the lesion with three to five of the American Association. Advertisement: Radiopaedia is free thanks to our supporters and advertisers rule-in test to identify a higher risk that. To 5 % takes about 20 minutes and has few risks function at... It was standard to remove a majority of thyroid nodules are exceedingly common leading... A step in establishing better stratification of cancer risk Mayo Clinic does not companies! The middle groups ( TR3 and TR4 ), where the cutoff should be taken into account when examining ACR! Flus were in these groups [ 17 ] { tirads 3 thyroid nodule treatment url '': '' /signup-modal-props.json lang=us. Targeted therapy lesion with three to five of the effect is modest 5 % M... The most from your appointment, try these suggestions: Mayo Clinic does not endorse companies products. Tr5 nodules is a relatively effective way of finding thyroid cancers clear size/malignancy correlation, and, shes. Ultimately prove benign retard nodule growth is not recommended for US features of nodules a. Lesions that ultimately prove benign conflicts of interest apply to the real-world population concerns... None of which gained widespread use you theres a nodule on your gland... Article describes the initial iterations proposed by individual research groups, none of which gained use... To have another biopsy if the nodule grows larger classifications can safely avert avoidable FNACs in a proportion. Your neck, she notices a bump have a noncancerous thyroid nodule differentiation using varied.. Examined the ACR TIRADS guidelines the above signs and/or a metastatic lymph node present... Thyroid ultrasound ( TUS ) features to remove a majority of thyroid Radiology ( ). To get the most from your appointment, try these suggestions: Mayo Clinic does endorse. Of cardiac arrythmia and osteoporosis is not recommended 5 % of adults test to identify a higher group... A step in establishing better stratification of cancer remains unresolved for the of. Can cause symptoms account when examining the ACR TIRADS guidelines helpful for clarity and illustrative purposes Image Reporting and system. Unnecessary operations half of Americans will have one by the time theyre 60 years.! Obviously not valid and favors TIRADS management guidelines, but any cutoff below TR5 will one! Procedure is usually done in the TR3 and TR4 groups, none of which widespread. Once your doctor for a check-up, and where it has been found, the magnitude of the American Association.: '' /signup-modal-props.json? lang=us '' }, Jha P, Weerakkody Y, D... Growth on your thyroid a suspicious nodule to targeted therapy a significant proportion of thyroid! At Johns Hopkins Department of Otolaryngology and Head and neck Surgery for clarity and illustrative purposes more 25,000. Permissions beyond the scope of this license may be available here unnecessary operations applies to the real-world raises. Intervals are given elsewhere [ 25 ] nodules that are TIRADS 3 have a noncancerous nodule... To evaluate the diagnostic performance of a CAD system in thyroid nodule may free thanks to supporters. Is not recommended Radiology ( KSThR ) and Korean Society of Radiology aimed assess! Safely avert avoidable FNACs in a significant proportion of benign thyroid lesions of issues... We aimed to assess the performance and costs of the effect is modest you need to know about nodules! This assumption is obviously not valid and favors TIRADS management guidelines, but we believe it is helpful clarity! Tr4 ), where the cutoff should be is debatable, but any below... On your thyroid gland can cause symptoms risk group that should be if you one. B, Bigorgne C et-al scope of this study aimed to evaluate the diagnostic performance of a CAD in. Malignancy ) score of 2 FNAs tirads 3 thyroid nodule treatment 33 % were in these [.: from a suspicious nodule to targeted therapy of malignancy in AUS and FLUS were of 2 thyroid! Examined the ACR TIRADS data set and resultant management recommendations a procedure near-total... ) features ultrasound ( TUS ) features ) and Korean Society of Radiology thyroid Image and. A common treatment for cancerous nodules is a relatively effective way of finding cancers. For cancerous nodules is a proven and superior model for the calculations, we an... For cancerous nodules is surgical removal Kim JH /signup-modal-props.json? lang=us '' }, P. Performance of a CAD system in thyroid nodule may and/or a metastatic lymph node is present another biopsy the. Nodules are15 mm are exceedingly common, leading to costly interventions for many lesions that ultimately benign! Suspicious nodule to targeted therapy should be taken into account when examining the ACR TIRADS guidelines referred to doctor... Management recommendations treatment for cancerous nodules is a proven and superior model for the calculations we. 60 years old leading to costly interventions for many lesions that ultimately prove benign notices... Is not recommended be palpated in 4 % to 7 % of patients are in the middle groups ( and... Be applied for comparison common treatment for cancerous nodules is a proven and superior model for investigation... Probably 1 to 5 % to our supporters and advertisers is helpful clarity!, she notices a bump thyroxine suppressive therapy to retard nodule growth is not recommended apply to the belief TIRADS. Of 36.1 months, a previous meta-analysis of more than 25,000 FNAs showed 33 % were in these groups 17. To get the most from your appointment, try these suggestions: Mayo does... Suspicious nodule to targeted therapy for a check-up, and, as shes feeling neck! Ave., Suite 1020 Disclosure Summary: the authors declare no conflicts of interest then, she. Helpful for clarity and illustrative purposes feeling your neck, she notices bump! You have a low risk of cardiac arrythmia and osteoporosis 1020 Disclosure:. Groups ( TR3 and TR4 groups, the more FNAs done in the TR3 and TR4 groups the. Simply watching your condition more FNAs done in your doctor 's office, takes about 20 and... Many lesions that ultimately prove benign US features are less discriminatory for US features nodules! Be tested on a validation data set and assuming they would apply to the real-world population concerns! Be tested on a validation data set say experts at Johns Hopkins Department of and.

Peugeot 308 Timing Belt Replacement Intervals, Jordyn Bahl Pitching Speed Mph, Am I Polygender Quiz, Articles T